NTNX vs NVDA

Nutanix demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9, signaling strong operational efficiency and financial stability. While the stock is currently in a severe technical downtrend (0/100), the valuation is highly attractive on a growth-adjusted basis with a PEG ratio of 0.86 and a Forward P/E of 17.66. The company maintains elite gross margins of 87.13% and a remarkable track record of beating earnings estimates over 25 consecutive quarters. Despite trading above the growth-based intrinsic value of $28.32, the combination of earnings acceleration and analyst targets suggests a strong recovery potential.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.